Synthesis of New 6-(4-Fluorophenyl)-5-(2-substituted pyrimidin-4-yl)imidazo[2,1-b] thiazole Derivatives and their Antiproliferative Activity against Melanoma Cell Line

  • Park, Jin-Hun (Biomaterials Center, Korea Institute of Science and Technology) ;
  • Oh, Chang-Hyun (Biomaterials Center, Korea Institute of Science and Technology)
  • Received : 2010.07.20
  • Accepted : 2010.08.19
  • Published : 2010.10.20


Synthesis of a new series of pyrimidinyl-imidazo[2,1-b]thiazole derivatives is described. Their antiproliferative activity against A375 human melanoma cell line was tested and the effect of substituents on the pyrimidinyl ring side chain was investigated. The biological results indicated that most of the newly synthesized compounds showed moderate activity against A375, compared with Sorafenib. Among all of these derivatives, the cyclic sulfamide derivatives IIIa, IIIb, and IIIe showed the most potent antiproliferative activity against A375 human melanoma cell line. The IC50 values of compounds IIIa,b were in nanomolar scale. In addition, compound IIIe ($IC_{50}=1.9\;{\mu}M$) also demonstrated more potent antiproliferative activity compared with Sorafenib ($IC_{50}=5.6\;{\mu}M$).


Supported by : Korea Institute of Science and Technology (KIST)


  1. Mohan, J.; Kiran, Indian J. Chem. 1991, 30B, 898.
  2. Gupta, G. D.; Jain, K. K.; Gupta, R. P.; Pujari, H. K. Indian J. Chem. 1983, 22B, 268.
  3. Robert, J. F.; Xicluna, A.; Panouse, J. J. Eur. J. Med. Chem. Chim. Ther. 1975, 10, 59.
  4. Amarouch, H.; Loiseau, P. R.; Bacha, C.; Caujolle, R.; Payard, M.; Loiseau, P. M.; Bories, C.; Gayral, P. Eur. J. Med. Chem. 1987, 22, 463.
  5. Andreani, A.; Bonazzi, D.; Rambaldi, M. Il Farmaco Ed. Sci. 1980, 35, 896.
  6. Andreani, A.; Bonazzi, D.; Rambaldi, M. Arch. Pharm. (Weinheim) 1982, 315, 451.
  7. Andreani, A.; Rambaldi, M.; Andreani, F.; Bossa, R.; Galatulas, I. Eur. J. Med. Chem. 1988, 23, 385.
  8. Andreani, A.; Rambaldi, M.; Locatelli, A.; Bossa, R.; Fraccari, A.; Galatulas, I. Pharm. Acta Helv. 1993, 68, 21.
  9. Andreani, A.; Rambaldi, M.; Locatelli, A.; Bossa, R.; Fraccari, A.; Galatulas, I. J. Pharm. Belg. 1993, 48, 378.
  10. Andreani, A.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Recanatini, M.; Garaliene, V. Bioorg. Med. Chem. 2000, 8, 2359.
  11. El-Subbagh, H. I.; Al-Khawad, I. E.; El-Bendary, E. R.; Al-Obaid, A. M. Saudi Pharm. J. 2001, 9, 14.
  12. Srimanth, K.; Rao, V. R.; Krishna, D. R. Arzneimittel-Forschung 2002, 52, 388.
  13. Andreani, A.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Lenaz, G.; Fato, R.; Bergamini, C.; Farruggia, G. J. Med. Chem. 2005, 48, 3085.
  14. Gursoy, E.; Güzeldemirci, N. U. Eur. J. Med. Chem. 2007, 42, 320.
  15. Lapierre, J.-M.; Liu, Y.; Tandon, M.; Ashwell, M. A. PCT Pat. Appl. WO 2010065893, June 10, 2010.
  16. Smith, R. A.; Dumas, J.; Adnane, L.; Wilhelm, S. M. Curr. Top. Med. Chem. 2006, 6, 1071.
  17. Barth, A.; Wanek, L. A.; Morton, D. L. J. Am. Coll. Surg. 1995, 181, 193.
  18. Atallah, E.; Flaherty, L. Curr. Treat. Options Oncol. 2005, 6, 185.
  19. Anderson, C. M.; Buzaid, A. C.; Legha, S. S. Oncol. (Williston Park) 1995, 9, 1149.
  20. Gray-Schopfer, V.; Wellbrock, C.; Marais, R. Nature 2007, 445, 851.
  21. Garbe, C.; Eigentler, T. K. Melanoma Res. 2007, 17, 117.
  22. Koon, H. B.; Atkins, M. B. Expert Rev. Anticancer Ther. 2007, 7, 79.
  23. Ashwell, M.; Tandon, M.; Lapierre, J.-M. PCT Pat. Appl. WO 2006044869, April 27, 2006.
  24. Tully, D. C.; Liu, H.; Chatterjee, A. K.; Alper, P. B.; Epple, R.; Williams, J. A.; Roberts, M. J.; Woodmansee, D. H.; Masick, B. T.; Tumanut, C.; Li, J.; Spraggon, G.; Hornsby, M.; Chang, J.; Tuntland, T.; Hollenbeck, T.; Gordon, P.; Harris, J. L.; Karanewsky, D. S. Bioorg. Med. Chem. Lett. 2006, 16, 5112.
  25. Townsend, C. A.; Basak, A. Tetrahedron 1991, 47, 2591.
  26. Kim, S. J.; Jung, M.-H.; Yoo, K. H.; Cho, J.-H.; Oh, C.-H. Bioorg. Med. Chem. Lett. 2008, 18, 5815.
  27. Eisen, T.; Ahmad, T.; Flaherty, K. T.; Gore, M.; Kaye, S.; Marais, R.; Gibbens, I.; Hackett, S.; James, M.; Schuchter, L. M.; Nathanson, K. L.; Xia, C.; Simantov, R.; Schwartz, B.; Poulin-Costello, M.; O’Dwyer, P. J.; Ratain, M. J. Br. J. Cancer 2006, 95, 581.

Cited by

  1. ChemInform Abstract: Synthesis of New 6-(4-Fluorophenyl)-5-(2-substituted pyrimidin-4-yl)imidazo[2,1-b]thiazole Derivatives and Their Antiproliferative Activity Against Melanoma Cell Line. vol.42, pp.11, 2011,
  2. Synthesis and Cytotoxic Activity of Some Novel N-Pyridinyl-2-(6-phenylimidazo[2,1-b]thiazol-3-yl)acetamide Derivatives vol.17, pp.12, 2012,
  3. Synthesis and plasma pharmacokinetics in CD-1 mice of a 18β-glycyrrhetinic acid derivative displaying anti-cancer activity vol.65, pp.3, 2012,
  4. Sulfamic Acid and Its N- and O-Substituted Derivatives vol.114, pp.4, 2014,
  5. Palladium-catalyzed microwave-assisted direct arylation of imidazo[2,1-b]thiazoles with aryl bromides: synthesis and mechanistic study vol.12, pp.30, 2014,
  6. ][1,3]Thiazole vol.52, pp.4, 2014,
  7. Broad-spectrum antiproliferative activity of a series of 6-(4-fluorophenyl)-5-(2-substituted pyrimidin-4-yl)imidazo[2,1-b]thiazole derivatives vol.25, pp.5, 2016,
  8. Improved antiproliferative activities of a new series of 1,3,4-thiadiazole derivatives against human leukemia and breast cancer cell lines vol.32, pp.5, 2016,
  9. ]thiazoles as Antimicrobial Agents vol.54, pp.1, 2016,
  10. Microwave-assisted green synthesis of new imidazo[2,1-b]thiazole derivatives and their antimicrobial, antimalarial, and antitubercular activities vol.43, pp.11, 2017,